PTHL Pheton Holdings Ltd
Stock Price & Overview

$1.97-0.075 (-3.67%)2:51 PM 02/28/25
NASDAQ | $USD | Post-Market: $2.00 +0.03 (+1.28%) 7:22 PM

PTHL Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

People Also Follow

Similar to PTHL

ETFs Holding PTHL

PTHL Company Profile

Pheton Holdings Ltd logo
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company’s proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
Employees
11
Founded
1998
Address
  • NET Building
  • Room 306
  • Hong Jun Ying South Road
  • Chaoyang District
  • Beijing, 100101
  • China
Phone Number
86 10 8481 7665

PTHL Revenue

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

PTHL does not currently pay a dividend.

PTHL Ownership

PTHL Peers

Risk

Technicals

PTHL SEC Filings

Press Releases

PTHL Income Statement

PTHL Balance Sheet

PTHL Cash Flow Statement

PTHL Long Term Solvency

Discover More

You may be interested in:

Pheton Holdings Ltd (PTHL) Frequently Asked Questions